Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 35: 459-460, 1989;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thornton, W. H.
Right arrow Articles by Edes, T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thornton, W. H., Jr
Right arrow Articles by Edes, T. E.

Clinical Chemistry, Vol 35, 459-460, Copyright © 1989 by American Association for Clinical Chemistry

Leukotriene B4 is measurable in serum of smokers and nonsmokers

WH Thornton Jr, EH Adelstein and TE Edes
Research Service, Harry S. Truman Memorial Veterans Hospital, Columbia, MO.

Leukotriene B4 (LTB4), an arachidonic acid metabolite released by neutrophils and macrophages, helps regulate host immune response to antigenic stimulation. LTB4 affects the chemokinesis, aggregation, and enzyme release of neutrophils and stimulates activity of cytotoxic T cells, natural killer cells, and suppressor T cells. LTB4 also has a positive affect on the margination of monocytes and macrophages in the lung in response to inflammatory stimuli. Cigarette smoking represents an inflammatory stimulus in the lung and affects (decreases) the in vitro release of LTB4 by alveolar, macrophages in comparison with that by alveolar macrophages of nonsmokers. By utilizing a sensitive and specific radioimmunoassay we have detected LTB4 concentrations in serum from smokers and nonsmokers. Furthermore, our preliminary data show mean LTB4 concentrations in the serum of smokers to be nearly 60-fold greater than those in nonsmokers, 211 (SEM 35) vs 3.6 (SEM 1.5). Because systemic quantities of LTB4 are now measurable, quantification of this immune system regulatory may be useful in evaluating inflammatory disease states.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American Association for Clinical Chemistry.